These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38871437)
1. Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force. Fleurence RL; Kent S; Adamson B; Tcheng J; Balicer R; Ross JS; Haynes K; Muller P; Campbell J; Bouée-Benhamiche E; García Martí S; Ramsey S Value Health; 2024 Jun; 27(6):692-701. PubMed ID: 38871437 [TBL] [Abstract][Full Text] [Related]
2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E; Value Health; 2013; 16(2):231-50. PubMed ID: 23538175 [TBL] [Abstract][Full Text] [Related]
3. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force. Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778 [TBL] [Abstract][Full Text] [Related]
4. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force. Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641 [TBL] [Abstract][Full Text] [Related]
5. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N; Value Health; 2016; 19(2):125-37. PubMed ID: 27021745 [TBL] [Abstract][Full Text] [Related]
6. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430 [TBL] [Abstract][Full Text] [Related]
7. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report. Malone DC; Ramsey SD; Patrick DL; Johnson FR; Mullins CD; Roberts MS; Willke RJ; Marshall DA Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155 [TBL] [Abstract][Full Text] [Related]
8. Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making. Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Daniel Mullins C Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1033-1039. PubMed ID: 28913966 [TBL] [Abstract][Full Text] [Related]
9. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E; Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250 [TBL] [Abstract][Full Text] [Related]
10. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P Value Health; 2007; 10(5):336-47. PubMed ID: 17888098 [TBL] [Abstract][Full Text] [Related]
11. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force. Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ Value Health; 2022 Oct; 25(10):1663-1672. PubMed ID: 36241338 [TBL] [Abstract][Full Text] [Related]
12. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force. Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):44-55. PubMed ID: 36215113 [TBL] [Abstract][Full Text] [Related]
13. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Brazier J; Ara R; Azzabi I; Busschbach J; Chevrou-Séverac H; Crawford B; Cruz L; Karnon J; Lloyd A; Paisley S; Pickard AS Value Health; 2019 Mar; 22(3):267-275. PubMed ID: 30832964 [TBL] [Abstract][Full Text] [Related]
14. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report. McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291 [TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety Outcomes. Singh S; Beyrer J; Zhou X; Swerdel J; Harvey RA; Hornbuckle K; Russo L; Ghauri K; Abi-Elias IH; Cox JS; Rodriguez-Watson C Drug Saf; 2023 Jan; 46(1):87-97. PubMed ID: 36396894 [TBL] [Abstract][Full Text] [Related]
16. Repeat: a framework to assess empirical reproducibility in biomedical research. McIntosh LD; Juehne A; Vitale CRH; Liu X; Alcoser R; Lukas JC; Evanoff B BMC Med Res Methodol; 2017 Sep; 17(1):143. PubMed ID: 28923006 [TBL] [Abstract][Full Text] [Related]
17. Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force. O'Donohoe P; Reasner DS; Kovacs SM; Byrom B; Eremenco S; Barsdorf AI; Arnera V; Coons SJ Value Health; 2023 May; 26(5):623-633. PubMed ID: 37121630 [TBL] [Abstract][Full Text] [Related]
18. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Kristensen FB; Husereau D; Huić M; Drummond M; Berger ML; Bond K; Augustovski F; Booth A; Bridges JFP; Grimshaw J; IJzerman MJ; Jonsson E; Ollendorf DA; Rüther A; Siebert U; Sharma J; Wailoo A Value Health; 2019 Jan; 22(1):13-20. PubMed ID: 30661627 [TBL] [Abstract][Full Text] [Related]
19. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Berger ML; Martin BC; Husereau D; Worley K; Allen JD; Yang W; Quon NC; Mullins CD; Kahler KH; Crown W Value Health; 2014 Mar; 17(2):143-56. PubMed ID: 24636373 [TBL] [Abstract][Full Text] [Related]
20. Health technology assessment in Australia: a role for clinical registries? Scott AM Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]